Drug shortages homepage

Welcome to Drug Shortages Canada, the website for reporting drug shortages and discontinuations in Canada. The Food and Drug Regulations require drug sellers to report when they are not able to meet demand for a product or when they stop selling a product. Information about the website and the regulations can be found on the About & Resources Page.

A shortage means, in respect of a drug, a situation in which the manufacturer to whom a document was issued under subsection C.01.014.2(1) that sets out the drug identification number assigned for the drug is unable to meet the demand for the drug.

A discontinuation means, in respect of a drug, a situation in which the manufacturer to whom a document was issued under subsection C.01.014.2(1) that sets out the drug identification number assigned for the drug, permanently ceases the sale of the drug.

Tier 3 drug shortages are those that have the greatest potential impact on Canada's drug supply and health care system. Impact is based on low availability of alternative supplies, ingredients or therapies. The Tier Assignment Committee (TAC), composed of federal and provincial/territorial governments, healthcare professionals, and industry stakeholders, makes recommendations on the tier assignment of drug shortages. The TAC assessment includes:

  • a review of the information gathered on the shortage issue, and
  • a thorough discussion on its potential impact and next steps.

Below are the newest and most recently updated Shortage and Discontinuation reports. Alternatively, please visit the Tier 3 page to see current Tier 3 Drug Shortages and associated shortage or discontinuation reports.

Drug pills

LEGEND

!!T3 denotes an actual Tier 3 shortage/discontinuation

!T3 denotes an anticipated Tier 3 shortage/discontinuation

Shortage Reports

Brand name Company Name Status Strength Update Date Updated View Report
CETROTIDE EMD SERONO, A DIVISION OF EMD INC., CANADA Anticipated shortage 0.25MG New Report 2022-05-21 161102
TECHNETIUM TC 99M TSC GE HEALTHCARE CANADA INC Resolved 2MG Updated Report 2022-05-21 156500
TEVA-BETAHISTINE TEVA CANADA LIMITED Resolved 8MG Updated Report 2022-05-21 160986
TEVA-BETAHISTINE TEVA CANADA LIMITED Resolved 16MG Updated Report 2022-05-21 160989
ELIGARD TOLMAR INTERNATIONAL LTD. Resolved 7.5MG Updated Report 2022-05-21 152360
INCLUNOX HP SANDOZ CANADA INCORPORATED Resolved 150MG Updated Report 2022-05-21 156450
DYSPORT AESTHETIC IPSEN BIOPHARMACEUTICALS CANADA INC Resolved 300UNIT Updated Report 2022-05-21 159136
APO-METHYLPHENIDATE ER APOTEX INC Actual shortage 54MG Updated Report 2022-05-21 159725
CORTROSYN INJ 0.25MG AMPHASTAR PHARMACEUTICALS, INC. Actual shortage 0.25MG Updated Report 2022-05-21 161043
OMNIPAQUE 240 GE HEALTHCARE CANADA INC Avoided shortage 518MG Updated Report 2022-05-20 160522

Discontinuation Reports

Brand name Company Name Status Strength Update Date Updated View Report
IMOVANE SANOFI-AVENTIS CANADA INC To be discontinued 5.0MG Updated Report 2022-05-16 160688
HEPTOVIR GLAXOSMITHKLINE INC To be discontinued 5MG New Report 2022-05-13 160503
HEPTOVIR GLAXOSMITHKLINE INC To be discontinued 100MG New Report 2022-05-13 160500
APO-BICALUTAMIDE APOTEX INC Discontinued 50MG Updated Report 2022-05-13 157376
ISOPTO CARPINE NOVARTIS PHARMACEUTICALS CANADA INC To be discontinued 4% New Report 2022-05-11 160361